PFE · News · 20260817N

Revenue Performance and Mix

PFIZER INC · 2026-08-17 · Importance 37 · Surprise 6 · In source text

Pfizer reported quarterly revenue of $15.03 billion, exceeding analyst expectations. Quarterly adjusted earnings were $0.77 per share, also above expectations. The company continues to face post-COVID revenue declines, indicating an ongoing shift away from COVID-related product demand.

Key facts

• Pfizer reported quarterly earnings of $0.77 EPS and revenue of $15.03 billion for the recent quarter. source
• Albert Bourla purchased US$1.0 million worth of Pfizer shares at an average price of US$26.34, increasing his holding by 9.6%. source
• Elevated Capital Advisors LLC cut its stake in shares of Pfizer Inc. by 53.2% in the second quarter and owned 21,185 shares after selling 24,066 shares during the period. source
• Farther Finance Advisors LLC increased its holdings in Pfizer Inc. by 49.5% in the second quarter to 395,297 shares valued at $9.5 million. source
• Massachusetts Financial Services Co. sold 360,819 shares of Pfizer Inc. in the second quarter and still holds over 56.5 million shares valued at approximately $1.38 billion. source
• Vontobel Holding Ltd. increased its stake in Pfizer Inc. by nearly 30% in the second quarter to over 916,000 shares valued at $22 million. source
• Ballentine Partners LLC cut its holdings in Pfizer Inc. by 18.2% in the second quarter and owned 84,928 shares after selling 18,852 shares during the quarter. source
• Burns Matteson Capital Management LLC purchased 20,337 shares of Pfizer Inc. stock in the second quarter, valued at approximately $490,000. source

Impact estimates